Skip to main content
Premium Trial:

Request an Annual Quote

Vitra Bioscience Raises $5.5M in Private Financing

NEW YORK, July 14 (GenomeWeb News) - Vitra Bioscience has raised $5.5 million in a second round of financing, the Mountain View, Calif.-based company said today.

 

Vitra said it will use the funds to help commercialize its CellCard System and to expand the company's product offerings. Alta Partners led the investment round with participation from Sofinnova Ventures, Mediphase Venture Partners, and Three Arch Partners.

 

The CellCard System facilitates parallel screening of multiple cell types for lead identification and optimization in drug discovery.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.